Liver Cancer Trial, Recruiting NCT07177742 Sponsor: Mu-qing Yang Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT07177742
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 19 and 80 years old (any gender)
  • People who are able to attend all required study visits and follow the study plan
  • People who are willing to take part and sign a consent form
  • People who have been diagnosed with colon adenocarcinoma (a specific type of colon cancer) confirmed through a laboratory tissue examination
  • People who have completed surgery to remove the affected part of the colon or rectum with the aim of curing the cancer

Who may not be able to join:

  • People who are not able to have the full surgical removal of the colorectal cancer
  • People who have a liver condition, such as chronic hepatitis B, hepatitis C, severe fatty liver, or cirrhosis
  • People whose surgery would require the removal of additional organs beyond the colon or rectum
  • People who also have another type of cancer, or a blood or immune system disease
  • People who received any cancer treatment before their tumour removal surgery, including radiation therapy, chemotherapy, or targeted therapy
  • People where, after surgery, it was found that a blood vessel in the surgical specimen could not provide a usable blood sample due to severe tumour involvement or other reasons (confirm with trial site)
  • People who experienced serious complications after surgery that delayed their treatment, rated as a severity level of III or above on a standard medical scale (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Mu-qing Yang
Registry
ClinicalTrials.gov
Start date
15 February 2021
Est. completion
30 November 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Liver metastasis.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov